Clinical Trial Update: Therapy of Early Chronic Phase CML With Higher-Dose Gleevec, Alpha Interferon, and Low-Dose Ara-C [Phase 2]

View source ↗

Summary

Phase 2 trial of higher-dose Gleevec (imatinib), alpha interferon, and low-dose cytarabine for early chronic phase chronic myeloid leukemia (CML); trial termina…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia
• Phase

Drugs mentioned

• Alpha Interferon (interferon alfa)
• Gleevec (Imatinib)
• low-dose Ara-C (cytarabine)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Myelogenous Leukemia, Chronic, Chronic Phase | Phase 2 | Status: TERMINATED | Results posted: 2018-10-09